2024 ESC Guidelines for the management of peripheral arterial and aortic diseases: Developed by the task force on the management of peripheral arterial and aortic …

L Mazzolai, G Teixido-Tura, S Lanzi, V Boc… - European heart …, 2024 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Global epidemiology of atrial fibrillation

F Rahman, GF Kwan, EJ Benjamin - Nature Reviews Cardiology, 2014 - nature.com
Atrial fibrillation (AF) is a major public health burden worldwide, and its prevalence is set to
increase owing to widespread population ageing, especially in rapidly develo** countries …

[HTML][HTML] Editor's choice--European Society for Vascular Surgery (ESVS) 2024 clinical practice guidelines on the management of asymptomatic lower limb peripheral …

J Nordanstig, CA Behrendt, I Baumgartner… - European Journal of …, 2024 - Elsevier
BIOTRONIK's First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter
vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularisation of …

JCS/JHRS 2020 guideline on pharmacotherapy of cardiac arrhythmias

K Ono, Y Iwasaki, M Akao, T Ikeda, K Ishii… - Circulation …, 2022 - jstage.jst.go.jp
The Japanese Circulation Society (JCS) published the “Guidelines for Pharmacological
Treatment of Arrhythmia” in 2004, and a revised edition was published in 2009. 1 Both …

Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: a systematic review and meta-analysis

V Ruddox, I Sandven, J Munkhaugen… - European journal of …, 2017 - academic.oup.com
Background In contemporary atrial fibrillation trials most deaths are cardiac related, whereas
stroke and bleeding represent only a small subset of deaths. We aimed to evaluate the long …

Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational …

AK Kakkar, I Mueller, JP Bassand, DA Fitzmaurice… - PloS one, 2013 - journals.plos.org
Background Limited data are available on the characteristics, clinical management, and
outcomes of patients with atrial fibrillation at risk of stroke, from a worldwide perspective. The …

Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation …

GYH Lip, L Frison, JL Halperin, DA Lane - Stroke, 2010 - Am Heart Assoc
Background and Purpose—The risk of stroke in patients with atrial fibrillation (AF) is not
homogeneous, and various clinical risk factors have informed the development of stroke risk …

Diabetes mellitus, blood glucose and the risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies

D Aune, T Feng, S Schlesinger, I Janszky… - Journal of Diabetes and …, 2018 - Elsevier
Background Diabetes and elevated blood glucose have been associated with increased risk
of atrial fibrillation in a number of epidemiological studies, however, the findings have not …

Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation

AJ Camm, G Accetta, G Ambrosio, D Atar, JP Bassand… - Heart, 2017 - heart.bmj.com
Objective We studied evolving antithrombotic therapy patterns in patients with newly
diagnosed non-valvular atrial fibrillation (AF) and≥ 1 additional stroke risk factor between …

[HTML][HTML] Atrial fibrillation and coronary artery disease: an integrative review focusing on therapeutic implications of this relationship

A Batta, J Hatwal, A Batta, S Verma… - World Journal of …, 2023 - ncbi.nlm.nih.gov
The incidence of both atrial fibrillation (AF) and coronary artery disease (CAD) increases
with advancing age. They share common risk factors and very often coexist. Evidence points …